Mr Larry Wayne Gardner, MD | |
143 Garden Homes Dr, Colville, WA 99114-9229 | |
(509) 684-3701 | |
(509) 684-5817 |
Full Name | Mr Larry Wayne Gardner |
---|---|
Gender | Male |
Speciality | Dermatology |
Location | 143 Garden Homes Dr, Colville, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114095437 | NPI | - | NPPES |
002016241 | Medicaid | NV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 3301 (Nevada) | Primary |
207ND0900X | Dermatology - Dermatopathology | 3301 (Nevada) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Mr Larry Wayne Gardner, MD 1200 E Columbia Ave, Colville, WA 99114-3354 Ph: (509) 684-3701 | Mr Larry Wayne Gardner, MD 143 Garden Homes Dr, Colville, WA 99114-9229 Ph: (509) 684-3701 |
News Archive
An early stage clinical trial of the experimental drug dimebon (latrepirdine) in people with Huntington's disease appears to be safe and may improve cognition. That is the conclusion of a study published today in the Archives of Neurology.
In honor of Lewy Body Dementia (LBD) Awareness Month, the Lewy Body Dementia Association proudly unveils, "The Profiles of LBD," a portrait series of families living with the disease.
ZenBio, Inc. industry leader in robust cell-based solutions, announced today the worldwide release of a new GroPro Cell Culture Growth Supplement. The GroPro product line allows for culturing of primary cells and cell lines without the concern for transmission of bovine prions and xenogeneic reactions.
The Government needs to resolve a number of issues to ensure the health service can cope with a national bowel screening programme, a leading Cancer Research UK scientist will tell conference delegates today (Tuesday).
Solvay Pharmaceuticals, Inc. announced that Phase IIIb data published in the January issue of Clinical Therapeutics confirm that CREON® (pancrelipase) Delayed-Release Capsules significantly improves a key measure of fat absorption in children aged 7-11 years who have exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF), EPI is a condition resulting from a deficiency in the production and/or secretion of pancreatic enzymes that are necessary to digest nutrients in food.
› Verified 5 days ago